ALDH1 converts aldehyde phosphoramide, an intermediate metabolite of the oxidative-alkylating agent, cyclophosphamide (CTX), into a non-toxic carboxyl phosphoramide, which plays a detoxifying role on CTX, leading to drug resistance of cancers to CTX [117]. The gene discussed is ALDH1A1; the disease is cancer.